| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |